Clinical Trial Update: Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates completion of a study evaluating onabotulinumtoxinA and abobotulinumtoxinA for crow's feet related to intrinsic aging …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrinsic Aging of Skin
• Solar Elastosis

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: The Maas Clinic | Conditions: Intrinsic Aging of Skin, Solar Elastosis | Phase 4 | Status: COMPLETED